CANADA LIFE ASSURANCE Co Sells 39,821 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

CANADA LIFE ASSURANCE Co trimmed its position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 36.9% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 67,967 shares of the company's stock after selling 39,821 shares during the quarter. CANADA LIFE ASSURANCE Co owned 0.05% of Henry Schein worth $4,701,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of HSIC. Olstein Capital Management L.P. boosted its position in shares of Henry Schein by 17.2% during the fourth quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company's stock valued at $7,543,000 after buying an additional 16,000 shares during the last quarter. Private Management Group Inc. boosted its holdings in Henry Schein by 5.7% during the 4th quarter. Private Management Group Inc. now owns 350,515 shares of the company's stock worth $24,256,000 after acquiring an additional 18,882 shares during the last quarter. Equitable Trust Co. purchased a new position in Henry Schein during the 4th quarter worth $417,000. Savant Capital LLC grew its stake in shares of Henry Schein by 43.9% in the 4th quarter. Savant Capital LLC now owns 4,651 shares of the company's stock worth $322,000 after acquiring an additional 1,420 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. raised its holdings in shares of Henry Schein by 29.9% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 15,854 shares of the company's stock valued at $1,113,000 after purchasing an additional 3,650 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, CEO Bradford C. Connett sold 4,036 shares of Henry Schein stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the sale, the chief executive officer now owns 62,688 shares in the company, valued at approximately $4,460,251.20. This trade represents a 6.05 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Philip A. Laskawy sold 2,604 shares of the business's stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the transaction, the director now directly owns 24,805 shares of the company's stock, valued at $1,762,147.20. The trade was a 9.50 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company's stock.

Henry Schein Stock Performance

Shares of NASDAQ:HSIC traded down $1.19 during midday trading on Wednesday, reaching $64.97. 1,059,826 shares of the company traded hands, compared to its average volume of 1,618,912. The firm's fifty day moving average price is $68.49 and its two-hundred day moving average price is $71.68. The firm has a market capitalization of $7.96 billion, a price-to-earnings ratio of 26.74, a price-to-earnings-growth ratio of 2.13 and a beta of 0.84. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a 12 month low of $60.56 and a 12 month high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.25 billion. During the same quarter in the prior year, the company earned $0.66 earnings per share. The company's quarterly revenue was up 5.8% on a year-over-year basis. On average, equities analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on HSIC shares. Bank of America raised shares of Henry Schein from an "underperform" rating to a "buy" rating and upped their price objective for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. StockNews.com downgraded Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. Wells Fargo & Company assumed coverage on Henry Schein in a report on Friday, February 14th. They set an "equal weight" rating and a $80.00 price target on the stock. Jefferies Financial Group raised their target price on Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a research report on Thursday, January 23rd. Finally, UBS Group lowered their target price on Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a research note on Wednesday, February 26th. Six research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $80.20.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.